Pharma Diseasemongers:Report
A leading medical journal says big pharma over-hypes or even makes up diseases for profit.
Pharmaceutical companies are selling their treatments through disease-mongering tactics that frame ordinary physiology in terms of disease, according to a series of papers published Tuesday in a leading medical journal.
The 11 publications in PLoS Medicine claimed the industry portrays mild problems as serious diseases, promotes risk factors as diseases, and makes medical problems out of ordinary life events such as menopause.
“Disease mongering turns healthy people into patients, wastes precious resources, and causes iatrogenic harm [harm induced by a physician's actions],” said a paper by the journal’s editors, Ray Moynihan and David Henry.